Within this well-defined and homogeneous patient cohort, we observed that the low expression of DNMT3A and presence of locoregional lymph node metastases were associated with disease-specific mortality, while N-status was a significant factor associated with locoregional recurrent disease after primary radiotherapy. The gene discussed is DNMT3A; the disease is metastatic malignant neoplasm in the lymph nodes.